Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Moragny

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2026
Drug-associated hypopigmentation: Disproportionality signals from the French National DatabaseMohamad Houssam Al Balkhi, Julien Moragny, Solène M Laville, et al.
Clinical Kidney Journal|January 9, 2025
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney diseaseSolène M Laville, Janice Vendar, Ziad A Massy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2020
Adverse Drug Reactions in Patients with CKDSolène M Laville, Valérie Gras-Champel, Julien Moragny, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 13, 2020
Association between renin-angiotensin system inhibitors and COVID-19 complicationsSophie Liabeuf, Julien Moragny, Youssef Bennis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2026
Drug-associated hypopigmentation: Disproportionality signals from the French National DatabaseMohamad Houssam Al Balkhi, Julien Moragny, Solène M Laville, et al.
Clinical Kidney Journal|January 9, 2025
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney diseaseSolène M Laville, Janice Vendar, Ziad A Massy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2020
Adverse Drug Reactions in Patients with CKDSolène M Laville, Valérie Gras-Champel, Julien Moragny, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 13, 2020
Association between renin-angiotensin system inhibitors and COVID-19 complicationsSophie Liabeuf, Julien Moragny, Youssef Bennis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Pageof 2